Four years treatment with Zoledronic Acid is superior to two years in protection against progressive bone disease in Multiple Myeloma

Gundesen MT*, Fredrik H. Schjesvold, Annette Juul Vangsted, Carsten Helleberg, Einar Haukas, Trine Silkjaer, Elena Manuela Teodorescu, Bo Amdi Jensen, Tobias Slordahl, Jon Thor Asmussen, Hareth Nahi, Niels Abildgaard, Thomas Lund

*Corresponding author for this work

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Original languageEnglish
Publication date27. Sept 2023
Publication statusPublished - 27. Sept 2023
Event20th International Myeloma Society Annual Meeting and Exposition - Athen, Greece
Duration: 27. Sept 202330. Sept 2023

Conference

Conference20th International Myeloma Society Annual Meeting and Exposition
Country/TerritoryGreece
CityAthen
Period27/09/202330/09/2023

Cite this